Holen Sie sich die Stockscreener-App
184.89
2.46%
-4.66
Vorhandelsmarkt:
184.00
-0.89
-0.48%
Schlusskurs vom Vortag:
$189.55
Offen:
$187.73
24-Stunden-Volumen:
791.86K
Relative Volume:
0.79
Marktkapitalisierung:
$10.91B
Einnahmen:
$551.35M
Nettoeinkommen (Verlust:
$-189.33M
KGV:
-56.17
EPS:
-3.2916
Netto-Cashflow:
$-35.09M
1W Leistung:
-2.41%
1M Leistung:
+18.93%
6M Leistung:
+53.73%
1J Leistung:
+103.31%
1-Tages-Spanne:
$183.25
$191.62
1-Wochen-Bereich:
$175.04
$191.62
52-Wochen-Spanne:
$73.16
$191.62
Glaukos Corp Stock (GKOS) Company Profile
Firmenname
Glaukos Corp
Sektor
Branche
Telefon
949-367-9600
Adresse
1 GLAUKOS WAY, ALISO VIEJO, CA
Compare GKOS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corp
|
184.89 | 11.18B | 551.35M | -189.33M | -35.09M | -3.2916 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Glaukos Corp Stock (GKOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | Eingeleitet | Goldman | Buy |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-05-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Eingeleitet | Truist | Buy |
| 2023-11-08 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-04 | Eingeleitet | Needham | Buy |
| 2022-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2022-02-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-11-03 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-09 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-17 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Eingeleitet | Jefferies | Hold |
| 2020-03-05 | Eingeleitet | Citigroup | Sell |
| 2020-02-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Hochstufung | Berenberg | Hold → Buy |
| 2019-12-12 | Herabstufung | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Eingeleitet | BTIG Research | Neutral |
| 2018-08-30 | Eingeleitet | Berenberg | Hold |
| 2018-08-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Bestätigt | Stifel | Hold |
| 2018-06-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | Cantor Fitzgerald | Buy |
| 2017-03-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2016-10-27 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Glaukos Corp Aktie (GKOS) Neueste Nachrichten
Zacks Research Issues Positive Estimate for Glaukos Earnings - MarketBeat
BlackRock Inc. Takes Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corp stock hits all-time high at 190.27 USD By Investing.com - Investing.com South Africa
Glaukos director Kliman sells $475,000 in shares - Investing.com
Glaukos (NYSE:GKOS) Director Gilbert Kliman Sells 2,500 Shares of Stock - MarketBeat
Glaukos (NYSE: GKOS) director sells shares after option exercise - Stock Titan
GKOS Stock Surges 67% Year to Date: What's Driving the Rally? - Yahoo Finance
Glaukos Corp stock hits all-time high at 190.27 USD - Investing.com
BTIG Research Boosts Glaukos (NYSE:GKOS) Price Target to $202.00 - MarketBeat
Zacks Research Has Negative Outlook for Glaukos Q2 Earnings - MarketBeat
GKOS Maintained by BTIG -- Price Target Raised to $202 - GuruFocus
Glaukos (NYSE:GKOS) Reaches New 12-Month HighShould You Buy? - MarketBeat
Glaukos (NYSE: GKOS) holder to sell 2,500 shares in 2026 - Stock Titan
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now - Yahoo Finance
Glaukos Announces Participation in Wells Fargo Healthcare Conference - Business Wire
145,202 Shares in Glaukos Corporation $GKOS Bought by TimesSquare Capital Management LLC - MarketBeat
Glaukos Market Cap More Than Doubles in a Year to $11B - Orange County Business Journal
Glaukos Corporation (NYSE:GKOS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Oppenheimer Asset Management Inc. Invests $2.73 Million in Glaukos Corporation $GKOS - MarketBeat
3 Stocks That May Be Trading Below Their Estimated Value By Up To 50% - Sahm
Walleye Capital LLC Takes $3.75 Million Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Insider Sold Shares Worth $10,784,659, According to a Recent SEC Filing - marketscreener.com
Glaukos COO Joseph Gilliam sells $10.7m in stock By Investing.com - Investing.com Canada
Insider Selling: Glaukos (NYSE:GKOS) COO Sells 60,000 Shares of Stock - MarketBeat
Glaukos COO Joseph Gilliam sells $10.7m in stock - Investing.com
Glaukos(GKOS.US) Officer Sells US$10.78 Million in Common Stock - Moomoo
Glaukos Corporation (GKOS) Stock Forecasts - Yahoo! Finance Canada
Glaukos (NYSE:GKOS) Hits New 12-Month HighHere's What Happened - MarketBeat
Glaukos Corp stock hits all-time high at 184.45 USD - Investing.com
Glaukos Corp stock hits all-time high at 184.45 USD By Investing.com - Investing.com Canada
Glaukos SVP & CFO Alex Thurman sells $3.6m in GKOS stock - Investing.com Nigeria
Insider Selling: Glaukos (NYSE:GKOS) CFO Sells 20,000 Shares of Stock - MarketBeat
Glaukos Insider Sold Shares Worth $3,602,600, According to a Recent SEC Filing - marketscreener.com
GLAUKOS Corp SEC Filing (Aug 11, 2026) - Stock Titan
Assenagon Asset Management S.A. Has $15.20 Million Stock Position in Glaukos Corporation $GKOS - marketbeat.com
Why Is Glaukos (NYSE:GKOS) Surging Toward the Top of Smallcap Medtech? - Kalkine Media
Glaukos Corporation $GKOS Shares Acquired by Bank of America Corp DE - MarketBeat
Quantinno Capital Management LP Raises Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full - The National Law Review
A Look at Glaukos Corp (GKOS) After 5.3% Gain -- GF Value $147.7 - GuruFocus
Glaukos (GKOS) Q2 2026 Earnings Call Transcript - theglobeandmail.com
Glaukos (NYSE: GKOS) insider Alex R. Thurman plans 20,000-share stock sale - Stock Titan
Glaukos Corp (GKOS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Dimensional Fund Advisors LP Sells 6,377 Shares of Glaukos Corporation $GKOS - MarketBeat
Royal Bank of Canada Purchases 12,253 Shares of Glaukos Corporation $GKOS - MarketBeat
California State Teachers Retirement System Purchases 11,871 Shares of Glaukos Corporation $GKOS - MarketBeat
First Trust Advisors LP Acquires 40,798 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos posts investor presentation outlining iDose TR, Epioxa launch and pipeline depth - TradingView
Insider Selling: Glaukos (NYSE:GKOS) Director Sells $88,005.75 in Stock - MarketBeat
Renaissance Technologies LLC Purchases New Shares in Glaukos Corporation $GKOS - MarketBeat
Glaukos (NYSE:GKOS) Raised to "Buy" at Wall Street Zen - MarketBeat
Finanzdaten der Glaukos Corp-Aktie (GKOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):